Ionis Pharmaceuticals IONS Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's effective income tax rate reconciliation, nondeductible expense, other, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's effective income tax rate reconciliation, nondeductible expense, other, amount?
- Ionis Pharmaceuticals (IONS) reported effective income tax rate reconciliation, nondeductible expense, other, amount of $1.05M in Q4 2025.
- How has Ionis Pharmaceuticals's effective income tax rate reconciliation, nondeductible expense, other, amount changed year-over-year?
- Ionis Pharmaceuticals's effective income tax rate reconciliation, nondeductible expense, other, amount increased by 2125.5% year-over-year, from $47K to $1.05M.
- What is the long-term trend for Ionis Pharmaceuticals's effective income tax rate reconciliation, nondeductible expense, other, amount?
- Over 2 years (2023 to 2025), Ionis Pharmaceuticals's effective income tax rate reconciliation, nondeductible expense, other, amount has grown at a 257.7% compound annual growth rate (CAGR), from $327K to $4.18M.